For the Inventor, By the Inventor

Enter assignee name

Gyeonggi-do, South Korea

Daewoong Co., Ltd.

USPTO Granted Patents = 14

EPO Patents = 10

Trademarks = 9

Forward Citations = 42

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Kyoung-Yun Kim (5 out of 5 patents)

Hye-Young Sul (5 out of 5 patents)

Kyoung-Min Min (4 out of 4 patents)

4. Seung Kook Park (3 out of 13 patents)

5. Chae Ha Yoon (2 out of 2 patents)

6. Sang Kil Lee (2 out of 8 patents)

7. Chung Sei Kim (2 out of 2 patents)

8. Hyeona Yim (1 out of 3 patents)

9. Cheong-Sei Kim (1 out of 1 patent)

10. Ji-Hoon Jung (1 out of 16 patents)

11. Jae Young Chang (1 out of 2 patents)

12. Sang-Wook Lee (1 out of 32 patents)

13. Yo Kyung Chung (1 out of 5 patents)

14. Sang-Kil Lee (1 out of 12 patents)

15. Hee-Chul Chang (1 out of 3 patents)

14 patents: Sort by Forward Citations

1. 11185503 - Stable liquid composition comprising botulinum toxin (2021-11-30),

2. 10619143 - Method and producing botulinum toxin (2020-04-14),

3. 10465179 - Medium composition for preparing botulinum toxin (2019-11-05),

4. 10308923 - Medium composition for preparing botulinum toxin (2019-06-04),

5. 10117927 - Medium composition for preparing botulinum toxin (2018-11-06),

6. 9926549 - Medium composition for preparing botulinum toxin (2018-03-27),

7. 9918937 - Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract (2018-03-20),

8. 9540378 - Composition comprising purine derivatives or salt thereof for preventing or treating atopic dermatitis (2017-01-10),

9. 9512418 - Method for production of botulinum toxin (2016-12-06),

10. 9199965 - Benzoimidazole derivatives and pharmaceutical composition comprising the same (2015-12-01),

11. 9155697 - Stable liquid compositions for treating stomatitis comprising epidermal growth factor (2015-10-13),

12. 8685440 - Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same (2014-04-01),

13. 8409586 - Stable liquid formulation of human growth hormone (2013-04-02),

14. 7811786 - Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor (2010-10-12),

Daewoong Co., Ltd. is a global leading pharmaceutical company based in South Korea. With a focus on research and development, the company specializes in developing innovative and high-quality pharmaceutical products. Daewoong Co., Ltd. aims to improve the health and well-being of individuals worldwide through its pharmaceutical solutions. With a broad portfolio of products in various therapeutic areas, Daewoong Co., Ltd. continues to make significant contributions to the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#62 in Gyeonggi-do

#777 in South Korea

#40,932 in the World

Gyeonggi-do, South Korea

Daewoong Co., Ltd.

Forward Citations = 42

56 inventors:

Kyoung-Yun Kim (5 out of 5 patents)

Hye-Young Sul (5 out of 5 patents)

Kyoung-Min Min (4 out of 4 patents)

4. Seung Kook Park (3 out of 13 patents)

5. Chae Ha Yoon (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…